Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by GOLDFISCHER CARL, Director. Officer active across 1 company, notably Epizyme, Inc.. Aggregated, 6 disclosures have been recorded. Split: 2 buys · 0 sell. History available since 11 June 2021. The latest transaction was disclosed on 17 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
6 of 6 declarations
GOLDFISCHER CARL is a Board Member of Epizyme, Inc. He participates in the governance of the company, contributing to strategic decision-making and overseeing operations. His experience in the biopharmaceutical sector is valuable for ensuring compliance and performance. Carl is committed to supporting the mission of Epizyme.